Literature DB >> 6185846

Hypomethylation distinguishes genes of some human cancers from their normal counterparts.

A P Feinberg, B Vogelstein.   

Abstract

It has been suggested that cancer represents an alteration in DNA, heritable by progeny cells, that leads to abnormally regulated expression of normal cellular genes; DNA alterations such as mutations, rearrangements and changes in methylation have been proposed to have such a role. Because of increasing evidence that DNA methylation is important in gene expression (for review see refs 7, 9-11), several investigators have studied DNA methylation in animal tumours, transformed cells and leukaemia cells in culture. The results of these studies have varied; depending on the techniques and systems used, an increase, decrease, or no change in the degree of methylation has been reported. To our knowledge, however, primary human tumour tissues have not been used in such studies. We have now examined DNA methylation in human cancer with three considerations in mind: (1) the methylation pattern of specific genes, rather than total levels of methylation, was determined; (2) human cancers and adjacent analogous normal tissues, unconditioned by culture media, were analysed; and (3) the cancers were taken from patients who had received neither radiation nor chemotherapy. In four of five patients studied, representing two histological types of cancer, substantial hypomethylation was found in genes of cancer cells compared with their normal counterparts. This hypomethylation was progressive in a metastasis from one of the patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6185846     DOI: 10.1038/301089a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  692 in total

1.  Cancer epigenetics takes center stage.

Authors:  A P Feinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

2.  Enzymatic regional methylation assay: a novel method to quantify regional CpG methylation density.

Authors:  Oliver Galm; Michael R Rountree; Kurtis E Bachman; Kam-Wing Jair; Stephen B Baylin; James G Herman
Journal:  Genome Res       Date:  2002-01       Impact factor: 9.043

3.  hMLH1 promoter hypermethylation in microsatellite instability-positive endometrial carcinoma. Cause or consequence?

Authors:  L H Ellenson
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

4.  Measurement of genome-wide DNA methylation predicts survival benefits from chemotherapy in non-small cell lung cancer.

Authors:  Min-Li Mo; Jie Ma; Zhao Chen; Bing Wei; Hui Li; Yong Zhou; Huaiyin Shi; Bhairavi Tolani; Joy Q Jin; Hsin-Hui Tseng; Dong Shen; Yi Zhan; Jun Li; David M Jablons; Rong-Qing Zhang; Yongjun Guo; Biao He; Hai-Meng Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2014-11-04       Impact factor: 4.553

Review 5.  DNA methylation in white blood cells: association with risk factors in epidemiologic studies.

Authors:  Mary Beth Terry; Lissette Delgado-Cruzata; Neomi Vin-Raviv; Hui Chen Wu; Regina M Santella
Journal:  Epigenetics       Date:  2011-07-01       Impact factor: 4.528

Review 6.  Cancer induction and suppression with transcriptional control and epigenome editing technologies.

Authors:  Shota Nakade; Takashi Yamamoto; Tetsushi Sakuma
Journal:  J Hum Genet       Date:  2017-11-14       Impact factor: 3.172

7.  Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma.

Authors:  V Greger; E Passarge; W Höpping; E Messmer; B Horsthemke
Journal:  Hum Genet       Date:  1989-09       Impact factor: 4.132

Review 8.  A new link between epigenetic progenitor lesions in cancer and the dynamics of signal transduction.

Authors:  Winston Timp; Andre Levchenko; Andrew P Feinberg
Journal:  Cell Cycle       Date:  2009-02-03       Impact factor: 4.534

9.  SPARSE INTEGRATIVE CLUSTERING OF MULTIPLE OMICS DATA SETS.

Authors:  Ronglai Shen; Sijian Wang; Qianxing Mo
Journal:  Ann Appl Stat       Date:  2013-04-09       Impact factor: 2.083

10.  Suppression of intestinal neoplasia by deletion of Dnmt3b.

Authors:  Haijiang Lin; Yasuhiro Yamada; Suzanne Nguyen; Heinz Linhart; Laurie Jackson-Grusby; Alexander Meissner; Konstantinos Meletis; Grace Lo; Rudolf Jaenisch
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.